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Abstract
Lipin-1 regulates lipid metabolism via its function as an enzyme in the triglyceride synthesis
pathway and as a transcriptional co-regulatory protein and is highly up-regulated in alcoholic fatty
liver disease. In the present study, using a liver specific lipin-1-deficient (lipin-1LKO) mouse
model, we aimed to investigate the functional role of lipin-1 in the development of alcoholic
steatohepatitis and explore the underlying mechanisms. Alcoholic liver injury was achieved by
pair feeding wild-type (WT) and lipin-1LKO mice with modified Lieber-DeCarli ethanol-
containing low fat diets for 4-wks. Surprisingly, chronically ethanol-fed lipin-1LKO mice showed
markedly greater hepatic triglyceride and cholesterol accumulation, and augmented elevation of
serum liver enzymes accompanied by increased hepatic pro-inflammatory cytokine expression.
Our studies further revealed that hepatic removal of lipin-1 in mice augmented ethanol-induced
impairment of hepatic fatty acid oxidation and lipoprotein production likely via deactivation of
PGC-1α, a prominent transcriptional regulator of lipid metabolism. Our findings demonstrate that
liver-specific lipin-1 deficiency in mice exacerbates the development and progression of
experimental alcohol-induced steatohepatitis. Pharmacological or nutritional modulation of
hepatic lipin-1 may be beneficial for the prevention or treatment of human alcoholic fatty liver
disease.
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Introduction
Alcoholic fatty liver disease (AFLD) is a major health problem in the United States.1 The
preponderance of studies have shown that excessive lipid accumulation in hepatocytes can
lead to more harmful forms of liver injury such as steatohepatitis, fibrosis, cirrhosis and end
stage liver injury in humans.1 The cellular and molecular mechanisms by which ethanol
consumption causes steatohepatitis are complex and elusive.
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There is little doubt that intrahepatic lipid accumulation is a key constituent of the
pathogenesis of AFLD.1 The primary storage form of lipid, triglyceride (TG), is primarily
synthesized from the acylation of glycerol-3-phosphate in liver. A critical step in this
process is the dephosphorylation of phosphatidic acid to form diacylglycerol. Studies from
several decades ago clearly showed that hepatic phosphatidic acid phosphatase (PAP)
activity is markedly increased in liver by chronic ethanol exposure but the genes encoding
the PAP enzymes remained elusive for many years.2–4 We now know that lipin family
proteins are the mammalian Mg2+-dependent PAP enzymes.5,6 The first member of the lipin
family, lipin-1, has now emerged as a vital regulator of lipid metabolism in several organs
including liver, adipose tissue, skeletal muscle and heart.6,7 Not surprisingly, we have
shown that lipin-1 expression is strongly induced by chronic ethanol exposure in mice,
suggesting that increased lipin-1-mediated PAP activity contributes to AFLD via it role in
driving glyceride synthesis.8,9
Interestingly, lipin-1 displays a second distinct function in regulating lipid metabolism that
is dependent on its subcellular localization. Lipin-1 enters the nucleus and directly interacts
with several transcription factors to function as a transcriptional co-regulatory protein.6,7
Nuclear lipin-1 co-activates the peroxisome proliferator-activated receptor α (PPARα) and
PPARγ coactivator 1α (PGC-1α) and inhibits the functions of sterol regulatory element
binding protein-1 (SREBP-1), leading to enhanced levels of enzymes involved in fatty acid
oxidation and reduced levels of genes encoding lipogenic enzymes.10–13 Lipin-1-mediated
PAP activity is dispensable for its ability to co-activate PPARα and PGC-1α, but is required
for the ability to repress SREBP-1.10
Several lines of evidence have suggested that ethanol-mediated dysregulation of lipin-1
function may contribute to the abnormalities in hepatic lipid metabolism associated with
alcoholic liver steatosis.8,9 As discussed above, the development of AFLD in rodents and
humans is associated with increased hepatic PAP activity.2–4 Our group recently discovered
that chronic ethanol feeding to mice significantly increased hepatic lipin-1 gene expression
and elevated cytosolic lipin-1 protein levels, suggesting that this accentuates the cytoplasmic
pro-lipogenic activity of lipin-1.8,9 In contrast, ethanol administration blocked lipin-1
nuclear entry in mouse livers, demonstrating that the nuclear functions of lipin-1, which
would promote fat oxidation and suppress de novo lipogenesis, are attenuated.9,14 The net
consequence of these ethanol-mediated effects on lipin-1 localization is predicted to
exacerbate fat accumulation in the liver. However, the causal role of lipin-1 in the
development of alcoholic fatty liver remains unknown.
To determine the metabolic effects of loss of lipin-1 on the development and pathogenesis of
AFLD, we developed and characterized mice with liver-specific lipin-1 deficiency.15
Unexpectedly, these mice actually exhibited increased hepatic TG accumulation at baseline
and with ethanol feeding. Loss of lipin-1 also exacerbated liver injury caused by ethanol.
For the first time, we provide evidence demonstrating that lipin-1 plays a crucial role the
hepatic response to chronic ethanol exposure and the present data suggest that lipin-1 plays a
protective role likely via transcriptional regulation of genes involved in fatty acid
catabolism.
Materials and Methods
Animal Experiments
Hepatocyte-specific lipin-1-deficient (lipin-1LKO) mice were generated by crossing
lipin-1flox/flox mice with albumin-promoter Cre (AlbCre) transgenic mice to generate
lipin-1flox/floxAlbCre+ mice.15,16 Lipin-1flox/flox mice not expressing Cre were used as
littermate LOX (WT) controls (genetic background: C57BL/6J and SV129).
Hu et al. Page 2
Hepatology. Author manuscript; available in PMC 2014 December 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Statistical Analysis
Data are presented as means±SEM. All data were analyzed by two-way ANOVA followed
by Tukey's multiple comparison procedure with a statistically significant difference defined
as a p value < 0.05.
Additional Materials and Methods are described in the Supporting information.
Results
Liver-specific deletion of lipin-1 exacerbates alcoholic fatty liver in mice
We sought to examine the role of lipin-1 in the development and pathogenesis of AFLD by
generating mice with liver-specific knockout of lipin-1 (lipin-1LKO) mice.15 Lipin-1LKO
mice were viable and outwardly normal on a chow diet. Western blotting analyses showed
the expression of a truncated lipin-1 protein (Fig.1A). The truncated lipin-1 protein results
from an alternative translational start site that generates a protein lacking the first 115 amino
acids. This protein is completely deficient in PAP activity but seems to retain at least partial
transcriptional regulatory function.15 However, in the liver, the nuclear concentration of the
truncated lipin-1 protein was nearly depleted either with or without ethanol feeding (Fig.
1A). We investigated the effects of hepatic lipin-1 deficiency on ethanol-induced fatty liver
by pair-feeding WT and lipin-1LKO mice with a modified Lieber-DeCarli low fat liquid diet
with ethanol for 4-wks.17 We tracked the alteration of food intake and body weight for the
entire 4-wks period and found that there were no significant differences among the ethanol
fed groups in food intake and serum alcohol concentrations were comparable in all ethanol-
fed WT or lipin-1LKO mice (Supporting Table 1; data not shown).
Hepatic PAP activity was substantially increased in ethanol-fed WT mice compared to the
WT controls (Fig.1B).9 Hepatic PAP activity was severely reduced in lipin-1LKO compared
to WT littermate controls. The increase in hepatic PAP activity in response to ethanol
feeding was largely abrogated in lipin-1LKO mice (Fig.1B). The expression of lipin-2 was
not affected by the loss of lipin-1 nor was it increased by ethanol exposure (Fig.1A).
Collectively, these data demonstrate that increased lipin-1 activity accounts for the large
increase in hepatic PAP activity after ethanol exposure in WT mice.
Histopathological analysis revealed that ethanol administration markedly increased
microvesicular and macrovesicular steatosis in lipin-1LKO mice compared to all other
groups (Fig. 2A,B). Accordingly, significantly higher levels of hepatic triglyceride and
cholesterol were detected in ethanol-fed lipin-1LKO mice than in other mice (Fig.2D,E).
Ethanol-fed lipin-1LKO mice also displayed significantly higher liver FFA content than did
mice in the other groups (Supporting Table 1). Ethanol feeding significantly increased liver
weight to body weight ratio and serum levels of ALT and AST in WT mice compared with
pair-fed WT controls (Fig.3A,B; Supporting Table 1). The increases in liver weight to body
weight ratio and serum ALT and AST levels were more pronounced in ethanol-fed
lipin-1LKO mice than respective pair-fed controls (Fig.3A,B; Supporting Table 1).
Immunohistochemical staining for collagen, an indicator of liver fibrosis, revealed modestly
higher levels of collagen deposition in the livers of the ethanol-fed lipin-1LKO mice
compared with the livers of ethanol-fed WT mice (Fig.2C). The mRNA expression levels of
early makers of hepatic fibrosis such as fibronectin and CD68 were highest in the livers of
ethanol-fed lipin-1LKO mice compared to all other groups (Supporting Fig.1A). Taken
together, our data clearly demonstrate that liver-specific deletion of lipin-1 exacerbates
alcoholic steatohepatitis in mice.
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Hepatic deletion of lipin-1 leads to hepatic inflammation in mice
Hepatic lipin-1 ablation led to significant increases in mRNA levels of two important
cytokines, tumor necrosis factor-alpha (TNF-α) and interleukin-1beta (IL-1β), up to 2–3 fold
in mice fed with a control diet (Fig.3D). Moreover, the magnitude of the increases in mRNA
expression levels of TNFα and IL-1β were significantly greater in ethanol-fed lipin-1LKO
mice than respective pair-fed controls (Fig.3D). While two pro-inflammatory molecules,
lipocalin-2 (LCN-2) and serum amyloid A-1 (SAA-1) were significantly elevated in ethanol-
fed WT mice compared to WT controls (Fig.3E)18–21 More strikingly, ethanol feeding to
lipin-1LKO mice substantially increased the mRNA levels of LCN-2 and SAA-1
approximately 25-fold and 50-fold, respectively, compared with WT controls, and
approximately 5-fold and 2-fold, respectively, compared with the ethanol-fed WT mice (Fig.
3E). Accordingly, the circulating levels of LCN-2 and SAA-1 were further increase in the
ethanol-fed lipin-1LKO mice (Supporting Fig.2). These observations demonstrate that
lipin-1LKO mice fed with or without ethanol are prone to development of hepatic
inflammation.
Chronic ethanol administration dramatically exacerbates oxidative stress in the liver of
ethanol-fed lipin-1LKO mice
Ethanol administration only slightly induced oxidative stress in WT mice, as demonstrated
by the levels of hepatic malondialdehyde (MDA) (Fig.3C).17 Hepatic lipin-1 ablation led to
a robust increase in the hepatic MDA levels up to nearly 8-fold in mice fed a control diet
compared to WT controls (Fig.3C). Remarkably, ethanol feeding to lipin-1LKO drastically
increased MDA levels approximately 16-fold compared with ethanol-fed WT mice, and
approximately 2-fold compared with lipin-1LKO fed with control diet (Fig.3C). The data
demonstrate that removal of lipin-1 generates oxidative stress in the liver, and the oxidative
stress is further augmented in response to ethanol administration in lipin-1LKO mice.
Liver-specific deletion of lipin-1 augments ethanol-mediated activation of two major
inflammatory regulators, nuclear Factor Kappa B (NF-kB) and nuclear factor of activated T
cells c4 (NFATc4), in mice
We dissected the mechanism for lipin-1 function in mediating hepatic inflammatory process
by investigating two major inflammatory regulators, NF-kB and NFATc4.22,23 Ethanol
feeding to WT mice or deletion of hepatic lipin-1 stimulated NFκB activity, demonstrated
by increased acetylated NFκB, enhanced phosphorylated IκBα, reduced IκBα protein and
elevated NF-κB DNA binding activity compared to WT control mice (Fig.4). The activation
of NF-κB was significantly augmented in the livers of ethanol-fed lipin-1LKO mice
compared to all other groups (Fig.4).
Ethanol feeding significantly increased nuclear accumulation of NFATc4 and decreased the
amount of NFATc4 in the cytoplasm in WT mice, and the increased nucleocytoplasmic
shuttling of NFATc4 was more pronounced in ethanol-fed lipin-1LKO mice (Fig.4).23,24
Collectively, these results clearly suggesting that deletion of lipin-1 led to activation of both
NFκB and NFATc4 and subsequently exacerbated inflammation in ethanol-fed lipin-1LKO
mice.
Hepatic removal of lipin-1 potentiates the perturbation of the rate of hepatic fatty acid β-
oxidation and VLDL-TAG secretion in mice fed ethanol
We assessed the total hepatic fatty acid β-oxidation capacity and VLDL-TAG secretion in
WT and Lipin-1LKO mice fed ethanol. The rate of hepatic fatty acid oxidation was
significantly decreased in the lipin-1LKO mice fed with ethanol compared to all other
groups (Fig.5A). Accordingly, ethanol feeding modestly but significantly reduced serum β-
Hu et al. Page 4
Hepatology. Author manuscript; available in PMC 2014 December 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
hydroxybutyrate (β-OHB), a marker for hepatic fatty acid oxidation, in lipin-1LKO mice
compared with ethanol-fed WT mice (Fig.5B).
Ethanol administration significantly decreased the rates of VLDL-TAG secretion in the
livers of WT mice compared with WT controls (Fig.5C).25 VLDL-TAG secretion rates were
significantly increased in lipin-1LKO mice fed a control diet compared with WT controls.12
Interestingly, ethanol feeding largely abolished the increase in VLDL-TAG secretion in
lipin-1LKO mice (Fig.5C).
Taken together, our results demonstrate that genetic removal of hepatic lipin-1 deranges the
overall rate of fatty acid oxidation and VLDL-TAG secretion, and these impairments are
further aggravated in response to ethanol administration in lipin-1LKO mice.
Chronic ethanol ingestion augments the suppression of PGC-1α in livers of lipin-1LKO
mice
We investigated the effect of chronic alcohol administration and lipin-1 deficiency on
PGC-1α.26,27,29 The mRNA and protein expression levels of PGC-1α were significantly
reduced in lipin-1LKO mice on control diet compared to WT littermates (Fig.6A,B). Liver
mRNA levels of PGC-1α were also significantly reduced in WT mice after ethanol feeding
and depletion of hepatic lipin-1 greatly exacerbated the inhibitory effects of ethanol on
PGC-1α (Fig.6A,B; Supporting Fig. 1B).
Ethanol feeding to lipin-1LKO mice substantially suppressed mRNAs of carnitine
palmitoyltransferase 1a (CPT1a), acyl-CoA oxidase (AOX), mitochondrial medium-chain
acyl-CoA dehydrogenase (MCAD) and mitochondrial long-chain acyl-CoA dehydrogenase
(LCAD) compared with respective controls or ethanol-treated WT mice (Fig.6C).
Additionally, ethanol feeding significantly increased hepatic PPARγ mRNA expression in
WT mice, and this increase was more pronounced in lipin-1LKO mice after ethanol
administration (Fig.6D). The mRNA levels of Cyp7A1, a PGC-1α target gene,28 were
markedly decreased by ethanol administration to WT mice and further significantly reduced
in ethanol-fed lipin-1LKO mice compared to all other groups (Fig.6D).
Together, these data suggest that liver-specific lipin-1 deficiency disrupts the hepatic
lipin-1-PGC-1α complex activity and leads to impaired capacity for fatty acid and
cholesterol catabolism.
Ethanol perturbs hepatic lipin-1 signaling in mouse AML-12 hepatocytes
We further dissected the mechanisms by which ethanol exposure disrupts nuclear lipin-1
signaling and causes fat accumulation in cultured mouse AML-12 hepatocytes.
Immunofluorescent staining of nuclei (blue, DAPI staining) and lipin-1(red) confirmed that
lipin-1α was localized in both the cytoplasm and the nucleus. Lipin-1β was also found
exclusively in the cytoplasm, and its sub-cellular localization was not affected by ethanol
exposure (Fig.7A).14 Ethanol exposure sequestered lipin-1α to the cytosol (Fig.7A)9,14
Treatment with either 4-methylpyrazole (4-MP) (an ADH inhibitor) or cyanamide (Cya) (an
ALDH2 inhibitor) essentially blocked the ability of ethanol to interfere with lipin-1α
signaling, indicating that ethanol metabolism is required (Fig.7B).
Ethanol significantly abolished the increase in PGC-1α co-transcriptional activity mediated
by lipin-1α in a dose-dependent manner in AML-12 cells (Fig.7C). Again, Treatment with
either 4-MP or Cya largely abolished the ability of ethanol to interfere with lipin-1α
signaling (Fig.7C).
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Ethanol or overexpression of lipin-1β significantly increased the TG accumulation in
AML-12 cells compared with controls and lipin-1β overexpression also mildly enhanced
ethanol-mediated TG accumulation (Fig.8).13,14 Importantly, the ethanol-mediated fat
accumulation was largely prevented in Ad-lipin-1α-overexpressing AML-12 cells compared
to Ad-GFP controls. Collectively, these data, taken with the results of lipin-1LKO mouse
studies, suggest that while lipin 1 is not required for alcohol-induced steatosis in mice,
lipin-1β may enhance ethanol-induced fat accumulation. On the other hand, lipin 1α, which
is more nuclear, may suppress lipid accretion possibly by enhancing fatty acid catabolism
and loss of this activity may enhance the development of steatosis in the lipin-1LKO mice.
Discussion
Intrahepatic lipid accumulation plays a pathogenic role in liver injury in response to chronic
ethanol exposure.1 Lipin-1 plays an important role in regulating lipid metabolism via its
cytoplasmic and nuclear effects.5–7 In the present study, we provide evidence demonstrating
that hepatic lipin-1 deficiency led to dramatically pronounced changes in terms of steatosis,
inflammation, and fibrosis in response to chronic ethanol administration compared to WT
mice. This suggests that the induction in lipin-1 in alcoholic fatty liver disease may play a
protective role by limiting inflammation, promoting efficient lipid storage, and/or
controlling the transcriptional regulation of fatty acid catabolism. Correlating closely with
the rapid onset and progression of steatosis and inflammation, hepatic PGC-1α abundance
was found to be severely diminished in ethanol-fed lipin-1LKO mice leading to reduced
expression of several PGC-1α target genes encoding fatty acid oxidation enzymes,
decreased rates of hepatic fatty acid oxidation, reduced generation of ketone bodies, and
impaired VLDL secretion. These findings can be interpreted to suggest that the loss nuclear
lipin-1 leads to these deleterious effects since lipin-1 is known to regulate these processes at
the transcriptional level.5–7,10 Indeed, lipin 1α overexpression suppressed alcohol-induced
TG accumulation potentially by transcriptionally activating fatty acid catabolism. However,
it is possible that loss of lipin-1 enzymatic activity may somehow be affecting signaling
pathways that lead to PGC-1α deactivation. For example, adipocyte-specific lipin 1 deletion
led to impaired cAMP signaling in that cell type,15 and this pathway seems to be very
important for regulation of PGC-1α in liver. Altogether, our results demonstrate that genetic
ablation of hepatic lipin-1 aggravates experimental alcohol-induced steatohepatitis in mice.
A marked increase in hepatic PAP activity has long been known to occur in alcoholic fatty
liver in animals and humans.2–4,9 We have previously shown that lipin-1 is strongly induced
in ethanol-induced fatty liver in mice and we sought to determine whether loss of lipin-1
would attenuate the increased PAP activity and intrahepatic triglyceride accumulation in
response to ethanol feeding. Interestingly, our present study showed that removal of lipin-1
from the liver effectively abolished the increase in hepatic PAP activity caused by ethanol,
but dramatically exacerbated ethanol-induced fatty liver in mice. Studies have demonstrated
that fld mice display liver steatosis partly due to increased hepatic lipin-2-mediated PAP
activity.6 Our data, however, suggest that it is unlikely that lipin-2-mediated PAP activity
contributes to aggravated fatty liver in ethanol-fed lipin-1LKO mice because the hepatic
total PAP activity was largely abolished. It is possible that the residual activity is sufficient
to maintain high rates of TG synthesis and that the accumulation of TG is a function of
reduced hepatic mobilization of fatty acids and catabolism of these metabolites in the
mitochondrial β-oxidation pathway. Indeed, we have recently shown that lipolytic rates are
reduced in adipose tissue of mice lacking lipin-1 in adipocytes.15
Nucleo-cytoplasmic localization of lipin-1 is a vital factor in the regulation of lipin-1
function as either a PAP enzyme or a transcriptional co-activator.6,7 Among the enzymes
involved in a number of lipid metabolism pathways we have examined (Supporting Fig.2),
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the major altered signaling molecule that most closely associated with fatty liver in ethanol-
fed lipin-1LKO mice was PGC-1α. PGC-1α is a pivotal regulator of lipid metabolism
through interacting with various transcriptional factors.26,27 Genetic ablation of lipin-1 not
only caused loss of PAP activity but also diminished the nuclear levels of lipin-1 in mouse
livers and the drastic liver responsiveness to ethanol administration in lipin-1LKO mice may
be due to loss of nuclear lipin-1 function and impaired capacity for fatty acid catabolism.
Indeed, we found that removal of lipin-1 led to exacerbated inhibition of a panel of enzymes
involved in fatty acid oxidation and augmented impairment of fatty acid oxidizing capacity
in the livers of ethanol-fed mice. The alterations in the rate of fatty acid oxidation in ethanol-
fed lipin-1LKO mice may suffice to elicit profound hepatic fat accumulation.
Induction of PGC-1α in cultured hepatic cells or in mice inhibits TG synthesis and
stimulates VLDL-TG secretion, which, in turn, attenuates high fat diet-induced hepatic
steatosis in mice.29 Interesting, while the precise role of lipin-1 in promoting or attenuating
hepatic VLDL secretion is still controversial, the effects of lipin-1 on VLDL-TG secretion is
dependent on its nuclear signaling and independent of its PAP activity.12 Therefore, it is
logical to speculate that impairment of the lipin-1-PGC-1α axis may induce TG synthesis
and suppress VLDL-TG secretion, ultimately leading to excess fat accumulation in the livers
of ethanol-fed lipin-1LKO mice.
Another intriguing discovery was that hepatic lipin-1 ablation markedly increased the
expression of pro-inflammatory cytokines and caused hepatic oxidative stress in mice fed
with or without ethanol, suggesting that endogenous lipin-1 has potent anti-inflammatory
properties. Recent accumulating evidence indicates an essential role of lipin-1 in the
regulation of the inflammatory process.23,30 For instance, in adipocytes, lipin-1 interacts
with NFATc4 to repress NFATc4 transcriptional activity, which in turn suppresses pro-
inflammatory cytokines such as TNF-α. Interestingly, we found that loss of hepatic lipin-1
resulted in the activation of both NF-κB and NFATc4 in mice, suggesting a possible cross-
talk between the NFATc4 and NF-κB pathways regulated by lipin-1. On the other hand, the
exacerbated inflammatory response could just be secondary to increased hepatic lipid
accumulation in ethanol-fed lipin-1LKO mice. Up-regulation of hepatic pro-inflammatory
cytokines and excess production of reactive oxygen species (ROS) in lipin-1LKO mice are
likely contribute to markedly elevated serum makers of liver injury. Additional studies
evaluating the ability of lipin-1 to repress the activity of transcriptional factors such as
NFATc4 or NF-κB and to attenuate the production of cytokines or ROS in response to LPS
or ethanol in Kupffer cells are currently under investigation in our laboratory.
The Lieber-DeCarli liquid diets enriched in polyunsaturated fat promotes ethanol-induced
liver injury in rodents.1 Our present study has utilized a modified Lieber-DeCarli low fat
ethanol containing liquid diet.17 It is possible that hepatic lipin-1 may be influenced by
dietary fat and composition. We are current investigating the effects of dietary fat and
composition on ethanol-mediated impairments of lipin-1.
The present study demonstrates that ethanol metabolism via ADH and ALDH2 induces
nucleocytoplasmic shuttling of lipin-1α, inhibiting PGC-1α activity and causing fat
accumulation in cultured hepatocytes. These in vitro findings further support the notion that
depletion of hepatic nuclear lipin-1 in lipin-1LKO mice may largely contribute to the drastic
liver responsiveness to ethanol challenge. The role of hepatic ethanol metabolism-induced
production of metabolites, redox state shift or reactive oxygen species in regulation of
lipin-1α nucleocytoplasmic shuttling merits investigation.
In summary, using liver specific lipin-1-null mice fed an ethanol containing diet, we
demonstrated for the first time that liver-specific deletion of lipin-1 leads to the rapid onset
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and progression of alcoholic steatohepatitis, providing novel insights into the biological
function of lipin-1 in alcoholic steatohepatitis. Our present findings suggest that the
development of nutritional or pharmacological agents to enhance nuclear lipin-1 activity
could be a promising approach toward developing new options for the prevention and
treatment of human alcoholic steatohepatitis.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
GRANTS
This study was supported by the National Institute on Alcoholism and Alcohol Abuse (grants AA015951 and
AA013623 to M.Y. and AA021228 to B.F.) and the National Institute of Diabetes and Digestive and Kidney
Diseases (grant DK078187 to B.F.).
Abbreviations used in the paper
ALT alanine aminotransferase
AST aspartate aminotransferase
AFLD alcoholic fatty liver disease
AMPK AMP-activated protein kinase
ACC acetyl-CoA carboxylase
AOX acyl-CoA oxidase
β-OHB beta-hydroxybutyate
Cya cyanamide
CYP7A1 cholesterol 7α-hydroxylase
CPT1a carnitine palmitoyltransferase 1a
DAG diacylglycerol
FAS fatty acid synthase
Fld fatty liver dystrophic
LCAD mitochondrial long-chain acyl-CoA dehydrogenase
GPAT1 mitochondrial glycerol-3-phosphate acyltransferase
LCN-2 lipocalin-2
MP methylpyrazole
MCAD mitochondrial medium-chain acyl-CoA dehydrogenase
MDA malondialdehyde
NF-kB nuclear Factor Kappa B
NFATc4 nuclear factor of activated T cells c4
PPAR peroxisome proliferator-activated receptor
PGC-1α peroxisome proliferator-activated receptor γ co-activator-1alpha
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PA phosphatidic acid
ROS reactive oxygen species
SAA-1 serum amyloid A-1
SIRT1 sirtuin 1
SREBP-1 sterol regulatory element-binding protein 1
SCD1 stearoyl-coenzyme A desaturase 1
TBARS thiobarbituric reactive substances
TNFα tumor necrosis factor-alpha
IL-1β interleukin-1beta
TAG Triacylglyceride
VLDL very low density lipoproteins
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Fig. 1.
Liver-specific deletion of lipin-1 exacerbates alcoholic fatty liver in mice. Wild-type (WT)
or lipin-1LKO (LKO) mice were pair-fed either a control LF diet or an ethanol-containing
diet for 4-wks. (A) Representative Western analysis of lipin-1or lipin-2 protein expression
levels. *Truncated lipin-1 protein. (B) Hepatic PAP activity. Results are expressed as means
±SEM (n=4–11 mice). Means without a common letter differ, p< 0.05.
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Fig. 2.
Liver-specific deletion of lipin-1 exacerbates alcoholic fatty liver in mice. Mice were fed as
described in Fig.1. (A) Pictures of mouse livers. (B) Hematoxylin and eosin (H&E) staining
(original magnification×40) of liver sections. (C) Immunohistochemical staining for
collagen. (D) Hepatic triglyceride (TG) levels. (E) Hepatic cholesterol levels. Results are
expressed as means±SEM (n=4–11 mice). Means without a common letter differ, p< 0.05
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Fig. 3.
Hepatic deletion of lipin-1 leads to hepatic inflammation in mice. Mice were fed as
described in Fig.1. (A) Serum ALT levels. (B) Serum AST levels. (C) Hepatic
malondialdehyde (MDA) levels. (D) Hepatic relative mRNA levels of TNF-α and IL-1β. (E)
Hepatic relative mRNA levels of LCN-2 and SAA1. Results are expressed as means±SEM
(n=4–11 mice). Means without a common letter differ, p< 0.05
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Fig. 4.
Liver-specific deletion of lipin-1 augments ethanol-mediated activation of two major
inflammatory regulators, NF-kB and NFATc4, in mice. Mice were fed as described in Fig.1.
(A) Hepatic NFκB binding activity. (B) Representative Western blot analysis of hepatic
acetylated NFκB (Ac-NFκB), NFκB, phosphorylated IκBα (p-IκBα), IκBα, and NFATc4.
(C) Hepatic relative protein levels. Results are expressed as means±SEM (n=4–11 mice).
Means without a common letter differ, p< 0.05
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Fig. 5.
Hepatic removal of lipin-1 potentiates the perturbation of the rate of hepatic fatty acid β-
oxidation and VLDL-TAG secretion in mice fed ethanol. Mice were fed as described in Fig.
1. (A) Rate of hepatic fatty acid β-oxidation. (B) Serum β-OHB levels. (C) Rate of hepatic
VLDL secretion. Results are expressed as means±SEM (n=4–11 mice). Means without a
common letter differ, p< 0.05
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Fig. 6.
Chronic ethanol ingestion augments the suppression of PGC-1α and its target genes in livers
of lipin-1LKO mice. Mice were fed as described in Fig.1. (A) Relative mRNA levels of
PGC-1α. (B) Representative Western blot analysis of hepatic PGC-1α protein expression
levels. (C) Relative mRNA expression levels of CPT1a, AOX, MCAD, LCAD. (D) Relative
mRNA levels of CYP7A1 and PPARγ. Results are expressed as means±SEM (n=4–11
mice). Means without a common letter differ, p< 0.05
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Fig. 7.
Ethanol perturbs hepatic lipin-1 signaling in mouse AML-12 hepatocytes. (A)&(B) AML-12
cells were transfected with expression vector driving expression of HA-lipin-1α, HA-
lipin-1β or control vector in the presence or absence of 4-methylpyrazole (4-MP),
cyanamide (Cya) or ethanol (E) (100 mM) for 18 h. The cells were subjected to
immunostaining with anti-HA (lipin-1) antibody (red), and nuclei were stained with DAPI
(blue). Representative photomicrographs of HA-lipin-1 (red) or DAPI (blue)
immunofluorescence in AML-12 cells. Original magnification×200. (C)&(D) AML-12 cells
were transfected with plasmids for (UAS)3-TK Luciferase and expression vector driving
expression of a Gal4-PGC-1α fusion protein along with control vector or HA-lipin-1α in the
presence or absence of ethanol (E) or inhibitors for 24 h. Cells then were harvested for assay
of luciferase activity. All data are means±SEM from at least 3 experiments. Means without a
common letter differ, p< 0.05.
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Fig. 8.
Overexpression of lipin-1α alleviates ethanol-mediated TG accumulation in AML-12 cell.
AML-12 cells were infected with AD-GFP, Ad-lipin-1α, Ad-lipin-1β. 48 h after infection,
ethanol (50 mM) was added. After incubation for 48 h, cellular TG content was measured by
a cellular enzymatic kit. (B) cellular TG content was measured by Nile Red Staining. All
data are means±SEM from at least 3 experiments. Means without a common letter differ, p<
0.05.
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